81 related articles for article (PubMed ID: 25769453)
1. Changed expression and function of P-gp in peripheral blood CD56 + cells predicting chemoresistance in non-Hodgkin lymphoma patients.
Han L; Guo X; Bian H; Zhou Y; Li T; Yang J
Cancer Biomark; 2015; 15(3):289-97. PubMed ID: 25769453
[TBL] [Abstract][Full Text] [Related]
2. Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer.
Han L; Wang YF; Zhang Y; Wang N; Guo XJ; Yang JK; Wang KP; Liu SN; Fan QX; Li K; Jiang JH; Wang QD
Cancer Chemother Pharmacol; 2012 Sep; 70(3):365-72. PubMed ID: 22782455
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of expression levels of multidrug resistance gene 1 (mdr1) mRNA, multidrug resistance-associated protein (MRP), amd P-glycoprotein (P-gp) with chemotherapy efficacy in malignant lymphomas].
Yang X; Jia L; Wei L; Zuo W; Song S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1177-9. PubMed ID: 12475404
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
[TBL] [Abstract][Full Text] [Related]
6. Modulation of multidrug resistance (MDR) in hematological malignancies.
Covelli A
Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
[TBL] [Abstract][Full Text] [Related]
7. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.
Foroutan B; Zitzelsberger H; Bauer V; Ruf AA; Baumgartner A; Anderson D
Arch Iran Med; 2011 Sep; 14(5):321-6. PubMed ID: 21888455
[TBL] [Abstract][Full Text] [Related]
9. [Research progress on microRNA associated with chemoresistance of NHL].
Zheng RL; Jiang YJ; Wang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1490-4. PubMed ID: 25338614
[TBL] [Abstract][Full Text] [Related]
10. The process behind the expression of mdr-1/P-gp and mrp/MRP in human leukemia/lymphoma.
Hirose M
Anticancer Res; 2009 Apr; 29(4):1073-7. PubMed ID: 19414348
[TBL] [Abstract][Full Text] [Related]
11. CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.
Takeshita A; Shinjo K; Yamakage N; Ono T; Hirano I; Matsui H; Shigeno K; Nakamura S; Tobita T; Maekawa M; Ohnishi K; Sugimoto Y; Kiyoi H; Naoe T; Ohno R
Br J Haematol; 2009 Jun; 146(1):34-43. PubMed ID: 19388933
[TBL] [Abstract][Full Text] [Related]
12. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
[TBL] [Abstract][Full Text] [Related]
13. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
14. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
[TBL] [Abstract][Full Text] [Related]
15. Expression of the novel all-trans retinoic acid-related resistance gene HA117 in pediatric solid tumors.
Duan W; Jin X; Xiu Y; Wang S; Zhu J; Liu H; Ding X; Jin X; Zhao Z; Wang X
J Pediatr Hematol Oncol; 2014 Jan; 36(1):45-50. PubMed ID: 23619123
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
[TBL] [Abstract][Full Text] [Related]
17. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders.
Webb M; Brun M; McNiven M; Le Couteur D; Craft P
Br J Haematol; 1998 Aug; 102(3):710-7. PubMed ID: 9722297
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53.
Foroutan B; Ruf AA; Costall B; Anderson D
J Pharmacol Toxicol Methods; 2007; 55(2):151-8. PubMed ID: 16870476
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
Janneh O; Jones E; Chandler B; Owen A; Khoo SH
J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of the human MRP1 and MRP2 mRNA expression in FACS-sorted peripheral blood CD4+, CD8+, CD19+, and CD56+ cells.
Oselin K; Mrozikiewicz PM; Pähkla R; Roots I
Eur J Haematol; 2003 Aug; 71(2):119-23. PubMed ID: 12890151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
